Table 1.
Demographic Data
| HALN* | ON* | P Value | |
|---|---|---|---|
| No. Patients | 38 | 52 | — |
| Age (range) | 71 (43–79) | 72 (54–82) | 0.87 |
| Sex (M/F) | 23/15 | 26/26 | 0.32 |
| Mean ASA Class | 2.8 | 2.6 | 0.07 |
| Presenting sx (%) | |||
| Hematuria | 31(82) | 37(71) | 0.31 |
| TCC* surveillance† | 13(25) | 37(71) | 0.29 |
| Systemic symptoms | 1(3) | 0(0) | 0.24 |
| Incidental | 0(0) | 2(4) | 0.22 |
| Location of Tumor | |||
| Right/Left | 22/16 | 29/23 | 0.84 |
| Renal Pelvis | 25(66) | 24(46) | 0.06 |
| Upper Ureter | 2(5) | 3(6) | 0.92 |
| Mid Ureter | 1(3) | 3(6) | 0.48 |
| Lower Ureter | 6(16) | 12(23) | 0.39 |
| Multifocal | 4(11) | 10(19) | 0.26 |
*
HALN=hand-assisted laparoscopic nephroureterectomy; ON= open nephroureterectomy; TCC=transitional cell carcinoma.
†
Patients with a history of bladder cancer with surveillance studies revealing an upper urinary tract lesion.